Pharmacotherapy of depression in oldage;Pharmakotherapie der altersdepression

Nervenarzt

Volumn 71, Issue 1, 2000, Pages 1-8

  Hegerl, U ^a   Moller H J ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

Antidepressants; Comorbidity; Depression; Older age; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; BIPERIDEN; CITALOPRAM; CLOZAPINE; CODEINE; DIGOXIN; DIPYRIDAMOLE; DISOPYRAMIDE; DOXEPIN; FLUOXETINE; ISOSORBIDE; LEVOMEPROMAZINE; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NIFEDIPINE; NORTRIPTYLINE; PERAZINE; PREDNISOLONE; PROMETHAZINE; QUINIDINE; RANITIDINE; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIHEXYPHENIDYL; VENLAFAXINE; WARFARIN; BETA INTERFERON;

COMORBIDITY; DEPRESSION; DRUG CHOICE; DRUG CLEARANCE; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; ELDERLY CARE; HUMAN; REVIEW; ARTICLE; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER; DRUG INTERACTIONS; GERIATRIC ASSESSMENT; HUMANS; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; INTERFERON-BETA; MULTIPLE SCLEROSIS;

EID: 0033628825     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050001     Document Type: Review

References (29)

1. Chan TY (1997) Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management. Drugs Aging 11:27-44
2. Cummings JL (1992) Depression in Parkinson's disease: a rewiew. Am J Psychiatry 149:443-454
3. Damitz BM (1997) Arzneimittelverbrauch älterer Menschen in Bremer Alten- und Pflegeheimen unter besonderer Berücksichtigung von Psychopharmaka. Gesundheitswesen 59:83-86
4. Eckert A, Reiff J, Müller WE (1998) Arzneimittelinteraktionen mit Antidepressiva. Psychopharmakotherapie 5:8-18
5. Evans M, Hammond M, Wilson K, Lye M, Copeland J (1997) Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry 12:817-824
6. Feighner JP (1995) Cardiovascular safety in depressed patients: focus on venlafaxine. J Clin Psychiatry 56:574-579
7. Flint AJ, Rifat SL (1994) A prospective study of lithium augmentation in antidepressant resistant geriatric depression. J Clin Psychopharmacol 14:353-356
8. Glassman AH, Johnson LL, Giardina EGV (1983) The use of imipramine in depressed patients with congestive heart failure. J Am Med Assoc 250:1997-2001
9. Goldberg RJ (1997) Antidepressant use in the elderly. Current status of nefazodone, venlafaxine and moclobemide. Drugs Aging 11:119-131
10. Goodnick PJ, Henry JH, Bucki VMV (1995) Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 56:128-136
11. Gottfries CG, Karlsson I, Nyth AL (1992) Treatment of depression in elderly patients with and without dementia disorders. Int Clin Psychopharmacol 6 [suppl 5]:55-64
12. Hegerl U, Möller HJ (1996) Nortriptylin: Stellenwert in der psychiatrischen Pharmakotherapie. Psychopharmakotherapie 3:13-27
13. Hegerl U, Bottlender R, Gallinat J, Kuss HJ, Ackenheil M, Möller HJ (1998) The serotonin syndrome scale: first results on validity. Eur Arch Psychiatry Clin Neurosci 248:96-103
14. Helmchen H, Linden M, Wernicke T (1996) Psychiatrische Morbidität bei Hochbetagten. Nervenarzt 67:739-750
15. Hoyberg OJ, Maragakis B, Mullin J et al. (1996) A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients. Acta Psychiatr Scand 93:184-190
16. Jacobs S, Zisook S (1998) Treatment of major depressions during ereavement. In: Nelson JC (ed) Geriatr Psychopharmacol. Dekker, New York, pp 115-126
17. Katz IR, Simpson GN, Curlik SM, Parmelee P, Muhly C (1990) Pharmacologic treatment of major depression for elderly patients in residential caresettings. J Clin Psychiatry 51 [suppl 7]:41-48
18. Laakmann G, Schüle C, Baghai T, Kieser M (1998) St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 31 [suppl]:54-59
19. Laux G (1997) Bessere Verträglichkeit neuer Antidepressiva. Psychopharmakotherapie 2 [suppl 6]:8-11
20. Mavrogiorgou P, Hegerl U (1997) Neurotoxizität. In: Müller-Oerlinghausen B, Greil W, Berghöfer A (Hrsg) Die Lithiumtherapie. Springer, Berlin Heidelberg New York, S 329-341
21. Murray GB, Cassem E (1998) Use of stimulants in depressed patients with medical illness. In: Nelson JC (ed) Geriatr Psychopharmacol. Dekker, New York, pp 245-257
22. Müller WE (1993) Pharmakodynamik und Pharmakokinetik von Psychopharmaka bei alten Patienten. In: Möller HJ, Rohde A (Hrsg) Psychische Krankheit im Alter. Springer, Berlin Heidelberg New York, S 353-361
23. Müller WE, Singer A, Wonnemann M, Häfner U, Rolli M, Schäfer C (1998) Hyperforin represents the neurotransmitter reuptake inhibiting constinuent of hypericum extract. Pharmacopsychiatry 31 [suppl]:16-21
24. Robinson RG, Schultz SK, Paradiso S (1998) Treatment of Poststroke Psychiatric Disorders. In: Nelson JC (ed) Geriatr Psychopharmacol Dekker, New York, pp 161-185
25. Roose SP, Glassman AH, Attia E, Woodring S (1994) Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 151:1735-1739
26. Roth M, Mountjoy CQ, Amrein R (1996) Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry 168:149-157
27. Tom T, Cummings JL (1998) Depression in Parkinson's disease. Pharmacological characteristics and treatment. Drugs Aging 12:55-74
28. Tune L, Carr S, Hoag E, Cooper T (1992) Anticholinergic effects of drug commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry 149:1393-1394
29. Van Marwijk H, Bekker FM, Nolen WA, Jansen P, van Nieuwkerk JF, Hop W (1990) Lithium augmentation in geriatric depression. J Affect Disord 20:217-223